These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 29696669)

  • 41. Clinical effectiveness and cost-effectiveness of collaborative care for depression in UK primary care (CADET): a cluster randomised controlled trial.
    Richards DA; Bower P; Chew-Graham C; Gask L; Lovell K; Cape J; Pilling S; Araya R; Kessler D; Barkham M; Bland JM; Gilbody S; Green C; Lewis G; Manning C; Kontopantelis E; Hill JJ; Hughes-Morley A; Russell A
    Health Technol Assess; 2016 Feb; 20(14):1-192. PubMed ID: 26910256
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cost-effectiveness of a primary care multidisciplinary Risk Assessment and Management Program for patients with diabetes mellitus (RAMP-DM) over lifetime.
    Jiao F; Wan EYF; Fung CSC; Chan AKC; McGhee SM; Kwok RLP; Lam CLK
    Endocrine; 2019 Feb; 63(2):259-269. PubMed ID: 30155847
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Costs and effectiveness of pharmacist-led group medical visits for type-2 diabetes: A multi-center randomized controlled trial.
    Wu WC; Taveira TH; Jeffery S; Jiang L; Tokuda L; Musial J; Cohen LB; Uhrle F
    PLoS One; 2018; 13(4):e0195898. PubMed ID: 29672567
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effectiveness of Targeted Insulin-Adherence Interventions for Glycemic Control Using Predictive Analytics Among Patients With Type 2 Diabetes: A Randomized Clinical Trial.
    Lauffenburger JC; Lewey J; Jan S; Makanji S; Ferro CA; Krumme AA; Lee J; Ghazinouri R; Haff N; Choudhry NK
    JAMA Netw Open; 2019 Mar; 2(3):e190657. PubMed ID: 30874782
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cost-effectiveness Analysis of a Stepped, Collaborative and Coordinated Health Care Network for Patients with Somatoform Disorders (Sofu-Net).
    Grochtdreis T; Brettschneider C; Shedden-Mora M; Piontek K; König HH; Löwe B
    J Ment Health Policy Econ; 2018 Jun; 21(2):59-69. PubMed ID: 29961045
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of multidisciplinary intensive targeted care in improving diabetes mellitus outcomes: a randomized controlled pilot study - the Integrated Diabetes Education, Awareness and Lifestyle modification in Singapore (IDEALS) Program.
    Tan E; Khoo J; Gani LU; Malakar RD; Tay TL; Tirukonda PS; Kam JW; Tin AS; Tang TY
    Trials; 2019 Sep; 20(1):549. PubMed ID: 31477163
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cost-effectiveness of sitagliptin-based treatment regimens in European patients with type 2 diabetes and haemoglobin A1c above target on metformin monotherapy.
    Schwarz B; Gouveia M; Chen J; Nocea G; Jameson K; Cook J; Krishnarajah G; Alemao E; Yin D; Sintonen H
    Diabetes Obes Metab; 2008 Jun; 10 Suppl 1():43-55. PubMed ID: 18435673
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A cluster randomised trial, cost-effectiveness analysis and psychosocial evaluation of insulin pump therapy compared with multiple injections during flexible intensive insulin therapy for type 1 diabetes: the REPOSE Trial.
    Heller S; White D; Lee E; Lawton J; Pollard D; Waugh N; Amiel S; Barnard K; Beckwith A; Brennan A; Campbell M; Cooper C; Dimairo M; Dixon S; Elliott J; Evans M; Green F; Hackney G; Hammond P; Hallowell N; Jaap A; Kennon B; Kirkham J; Lindsay R; Mansell P; Papaioannou D; Rankin D; Royle P; Smithson WH; Taylor C
    Health Technol Assess; 2017 Apr; 21(20):1-278. PubMed ID: 28440211
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cost-effectiveness analysis of doctor-pharmacist collaborative prescribing for venous thromboembolism in high risk surgical patients.
    Hale A; Merlo G; Nissen L; Coombes I; Graves N
    BMC Health Serv Res; 2018 Oct; 18(1):749. PubMed ID: 30285744
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Stratified patient-centered care in type 2 diabetes: a cluster-randomized, controlled clinical trial of effectiveness and cost-effectiveness.
    Slingerland AS; Herman WH; Redekop WK; Dijkstra RF; Jukema JW; Niessen LW
    Diabetes Care; 2013 Oct; 36(10):3054-61. PubMed ID: 23949558
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Newer agents for blood glucose control in type 2 diabetes: systematic review and economic evaluation.
    Waugh N; Cummins E; Royle P; Clar C; Marien M; Richter B; Philip S
    Health Technol Assess; 2010 Jul; 14(36):1-248. PubMed ID: 20646668
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Economic evaluation of Indigenous health worker management of poorly controlled type 2 diabetes in north Queensland.
    Segal L; Nguyen H; Schmidt B; Wenitong M; McDermott RA
    Med J Aust; 2016 Mar; 204(5):1961e-9. PubMed ID: 26985851
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The impact of supported telemetric monitoring in people with type 2 diabetes: study protocol for a randomised controlled trial.
    Wild S; Hanley J; Lewis S; McKnight J; McCloughan L; Padfield P; Paterson M; Pinnock H; McKinstry B
    Trials; 2013 Jul; 14():198. PubMed ID: 23829417
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Patient-centred and professional-directed implementation strategies for diabetes guidelines: a cluster-randomized trial-based cost-effectiveness analysis.
    Dijkstra RF; Niessen LW; Braspenning JC; Adang E; Grol RT
    Diabet Med; 2006 Feb; 23(2):164-70. PubMed ID: 16433714
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A cluster-randomized trial to estimate the effect of mobile screening and treatment feedback on HbA1c and diabetes-related complications in Tshwane primary health care clinics, South Africa.
    Webb EM; Rheeder P
    Prim Care Diabetes; 2017 Dec; 11(6):546-554. PubMed ID: 28690088
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Five-Year Cost-effectiveness of the Multidisciplinary Risk Assessment and Management Programme-Diabetes Mellitus (RAMP-DM).
    Jiao FF; Fung CSC; Wan EYF; Chan AKC; McGhee SM; Kwok RLP; Lam CLK
    Diabetes Care; 2018 Feb; 41(2):250-257. PubMed ID: 29246949
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluating the cost-effectiveness of laparoscopic adjustable gastric banding versus standard medical management in obese patients with type 2 diabetes in the UK.
    Pollock RF; Muduma G; Valentine WJ
    Diabetes Obes Metab; 2013 Feb; 15(2):121-9. PubMed ID: 22882321
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cost-effectiveness of a multicondition collaborative care intervention: a randomized controlled trial.
    Katon W; Russo J; Lin EH; Schmittdiel J; Ciechanowski P; Ludman E; Peterson D; Young B; Von Korff M
    Arch Gen Psychiatry; 2012 May; 69(5):506-14. PubMed ID: 22566583
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cost-effectiveness of pharmacist-led care versus usual care in type 2 diabetic Jordanians: a Markov modeling of cardiovascular diseases prevention.
    Mousa R; Hammad E
    Expert Rev Pharmacoecon Outcomes Res; 2021 Oct; 21(5):1069-1079. PubMed ID: 33213221
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A pragmatic randomised controlled trial of the effectiveness and cost-effectiveness of 'PhysioDirect' telephone assessment and advice services for physiotherapy.
    Salisbury C; Foster NE; Hopper C; Bishop A; Hollinghurst S; Coast J; Kaur S; Pearson J; Franchini A; Hall J; Grove S; Calnan M; Busby J; Montgomery AA
    Health Technol Assess; 2013 Jan; 17(2):1-157, v-vi. PubMed ID: 23356839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.